Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2008, Vol. 111, No. 4, pp. 2142-2151.
Prepublished online as a Blood First Edition Paper on December 20, 2007; DOI 10.1182/blood-2007-08-105221.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-08-105221v1
111/4/2142    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goping, I. S.
Right arrow Articles by Bleackley, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goping, I. S.
Right arrow Articles by Bleackley, R. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 3, 2007
Accepted December 13, 2007

Cytotoxic T lymphocytes overcome Bcl-2 inhibition: target cells contribute to their own demise

Ing Swie Goping, Tracy Sawchuk, Aja Rieger, Irene Shostak, and R. Chris Bleackley*

Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada

* Corresponding author; email: chris.bleackley{at}ualberta.ca.

Cytotoxic T lymphocytes (CTL) eliminate pathogenic cells in large part through the activity of the serine protease granzyme B (grB). However, while the apoptotic activity of grB is blocked by over-expression of Bcl-2, CTL can still kill target cells through an ill-defined Bcl-2-independent pathway. In this report, we have identified key modulators of this Bcl-2-independent cell death pathway which is induced by CTL and not purified components. Surprisingly, activation of this pathway is reliant on grB. Furthermore, this novel pathway requires mitochondrial contribution through triggering of permeability transition and generation of reactive oxygen species, yet is functional in the absence of Bax/Bak. This pathway stimulates movement of target cell mitochondria toward the point of contact with the CTL and importantly, inhibition of this directed movement attenuates killing. Therefore we propose that CTL initiate a target cell response which activates multiple mitochondrial pathways. This ensures that CTL can eliminate those target cells that have compromised apoptotic potential due to over-expression of Bcl-2.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020